This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethoxy group, is particularly valuable in the development of drugs targeting the central nervous system (CNS), such as antidepressants and anxiolytics. The chiral (S)-configuration is crucial for ensuring the desired biological activity and selectivity in drug molecules. Additionally, it is employed in research settings for the development of novel therapeutic agents, particularly those involving modulation of neurotransmitter systems. Its unique chemical properties also make it a candidate for use in agrochemicals, specifically in the design of pesticides and herbicides with enhanced efficacy and specificity.